Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Assunta Bianco

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
CNS Drugs|July 28, 2021
The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative ReviewMarco Biolato, Assunta Bianco, Matteo Lucchini, et al.
Journal of Neuroimmunology|November 26, 2025
Wash-out duration and lymphocyte count in switching from fingolimod to ofatumumab: A case report and literature reviewAssunta Bianco, Rosellina Russo, Alessandra Cicia, et al.
Multiple Sclerosis and Related Disorders|June 29, 2020
Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case reportMatteo Lucchini, Assunta Bianco, Paola Del Giacomo, et al.
Translational Neuroscience|August 12, 2022
Neurosarcoidosis presenting as longitudinally extensive myelitis: Diagnostic assessment, differential diagnosis, and therapeutic approachAlessandra Cicia, Viviana Nociti, Assunta Bianco, et al.
Diagnostics (Basel, Switzerland)|December 11, 2025
Adult Onset of Type 2 Familial Hemophagocytic Lymphohistiocytosis After SARS-CoV-2 Vaccination with an Unusual Neurological Onset: The Great MimicFlaminia Bellisario, Assunta Bianco, Francesco D'Alo', et al.
Journal of the Neurological Sciences|July 19, 2017
Sativex® effects on promoter methylation and on CNR1/CNR2 expression in peripheral blood mononuclear cells of progressive multiple sclerosis patientsMassimo Santoro, Massimiliano Mirabella, Chiara De Fino, et al.
Multiple Sclerosis and Related Disorders|September 21, 2016
Severe dyspnoea with alteration of the diffusion capacity of the lung associated with fingolimod treatmentAssunta Bianco, Agata Katia Patanella, Viviana Nociti, et al.
Brain and Behavior|May 6, 2018
Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patientsViviana Nociti, Marco Biolato, Chiara De Fino, et al.
European Journal of Neurology|March 20, 2026
Paramagnetic Rim Lesions in Highly Active Multiple Sclerosis at the Time of Disease Diagnosis: Prevalence Data and Clinical ImplicationsAlessandra Cicia, Matteo Lucchini, Gianluca Di Fiore, et al.
Journal of Neuroimmunology|May 23, 2012
Type 1 immune response in progressive multiple sclerosisGiovanni Frisullo, Domenico Plantone, Alessandro Marti, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
CNS Drugs|July 28, 2021
The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative ReviewMarco Biolato, Assunta Bianco, Matteo Lucchini, et al.
Journal of Neuroimmunology|November 26, 2025
Wash-out duration and lymphocyte count in switching from fingolimod to ofatumumab: A case report and literature reviewAssunta Bianco, Rosellina Russo, Alessandra Cicia, et al.
Multiple Sclerosis and Related Disorders|June 29, 2020
Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case reportMatteo Lucchini, Assunta Bianco, Paola Del Giacomo, et al.
Translational Neuroscience|August 12, 2022
Neurosarcoidosis presenting as longitudinally extensive myelitis: Diagnostic assessment, differential diagnosis, and therapeutic approachAlessandra Cicia, Viviana Nociti, Assunta Bianco, et al.
Diagnostics (Basel, Switzerland)|December 11, 2025
Adult Onset of Type 2 Familial Hemophagocytic Lymphohistiocytosis After SARS-CoV-2 Vaccination with an Unusual Neurological Onset: The Great MimicFlaminia Bellisario, Assunta Bianco, Francesco D'Alo', et al.
Journal of the Neurological Sciences|July 19, 2017
Sativex® effects on promoter methylation and on CNR1/CNR2 expression in peripheral blood mononuclear cells of progressive multiple sclerosis patientsMassimo Santoro, Massimiliano Mirabella, Chiara De Fino, et al.
Multiple Sclerosis and Related Disorders|September 21, 2016
Severe dyspnoea with alteration of the diffusion capacity of the lung associated with fingolimod treatmentAssunta Bianco, Agata Katia Patanella, Viviana Nociti, et al.
Brain and Behavior|May 6, 2018
Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patientsViviana Nociti, Marco Biolato, Chiara De Fino, et al.
European Journal of Neurology|March 20, 2026
Paramagnetic Rim Lesions in Highly Active Multiple Sclerosis at the Time of Disease Diagnosis: Prevalence Data and Clinical ImplicationsAlessandra Cicia, Matteo Lucchini, Gianluca Di Fiore, et al.
Journal of Neuroimmunology|May 23, 2012
Type 1 immune response in progressive multiple sclerosisGiovanni Frisullo, Domenico Plantone, Alessandro Marti, et al.
Pageof 4